v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 53,826 $ 86,952
Accounts receivable, net 54,697 47,682
Inventories 26,963 12,158
Prepaid expenses 3,757 3,349
Other current assets 3,674 1,201
Total current assets 142,917 151,342
Property and equipment, net 5,371 3,222
Operating lease right-of-use assets 7,133 7,185
Intangible assets, net 48,040 48,754
Goodwill 21,208 21,208
Other assets 1,199 858
Total assets 225,868 232,569
Current Liabilities    
Accounts payable 23,360 9,236
Accrued expenses 35,591 40,791
Current portion of operating lease liabilities 2,529 1,718
Current portion of contingent royalty obligation payable to Evolus Founders 12,523 11,215
Current portion of contingent milestone payment 1,302 0
Total current liabilities 75,305 62,960
Long-term portion of operating lease liabilities 6,371 6,755
Long-term portion of contingent royalty obligation payable to Evolus Founders 19,659 33,550
Long-term portion of term loan, net of discount and issuance costs 146,096 121,506
Long-term portion of contingent milestone payment 1,515 2,270
Deferred tax liability 28 6
Total liabilities 248,974 227,047
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit)    
Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of December 31, 2025 and 2024, respectively 0 0
Common Stock, $0.00001 par value; 100,000,000 shares authorized; 65,008,183 and 63,497,548 shares issued and outstanding as of December 31, 2025 and 2024, respectively 1 1
Additional paid-in capital 638,089 615,825
Accumulated other comprehensive loss (156) (905)
Accumulated deficit (661,040) (609,399)
Total stockholders’ equity (deficit) (23,106) 5,522
Total liabilities and stockholders’ equity (deficit) $ 225,868 $ 232,569
Common stock, shares, issued (in shares) 65,008,183 63,497,548
Common stock, shares, outstanding (in shares) 65,008,183 63,497,548